Suppr超能文献

95例霍奇金病的临床病理研究

[Clinico-pathologic studies of 95 cases of Hodgkin's disease].

作者信息

Wang Q L

机构信息

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing.

出版信息

Zhonghua Zhong Liu Za Zhi. 1991 Sep;13(5):385-8.

PMID:1782853
Abstract

From 1961 through 1986, 95 cases of Hodgkin's disease were biopsied in our hospital. Sex distribution: male 70, female 25. Age incidence: 27% were under 20 years and 75% under 40. 93% of lesions had originated from the lymph nodes. Clinical stage: I 14, II 37, III 25 and IV 19 cases. 20 patients were treated by chemotherapy, 26 by radiotherapy and 49 by combined chemotherapy and radiotherapy. The CR + PR rate was 86.2% and the 1-, 3-, 5- and 10-year survival rates were 83.2% (79/95), 57.6% (53/92), 46.4% (32/69) and 31.3% (15/48), respectively. The results showed that the 4 pathological types (LP, NS, MC, LD) and 10 subtypes (D,N in LP; LP, MC, LD in NS; LP, MC, LD in MC; R, DF in LD) and the predominance of reticulum cells (S-R cells, HD cells, histiocytes, lymphocytes, fibrosis, collagenous changes) in the tumor were all irrelevant to the prognosis (P greater than 0.05). However, the clinical stage, immediate response and the method of treatment were very prognostic (P less than 0.05) The authors believe that intensive chemotherapy combined with radiotherapy and intensive radiotherapy could lead to long survival.

摘要

1961年至1986年期间,我院对95例霍奇金病患者进行了活检。性别分布:男性70例,女性25例。年龄发病率:20岁以下者占27%,40岁以下者占75%。93%的病变起源于淋巴结。临床分期:Ⅰ期14例,Ⅱ期37例,Ⅲ期25例,Ⅳ期19例。20例患者接受化疗,26例接受放疗,49例接受化疗联合放疗。完全缓解(CR)+部分缓解(PR)率为86.2%,1年、3年、5年和10年生存率分别为83.2%(79/95)、57.6%(53/92)、46.4%(32/69)和31.3%(15/48)。结果显示,4种病理类型(淋巴细胞为主型、结节硬化型、混合细胞型、淋巴细胞消减型)和10个亚型(淋巴细胞为主型中的弥漫性、结节性;结节硬化型中的淋巴细胞为主型、混合细胞型、淋巴细胞消减型;混合细胞型中的淋巴细胞为主型、混合细胞型、淋巴细胞消减型;淋巴细胞消减型中的网状细胞型、弥漫性纤维化型)以及肿瘤中网状细胞(S-R细胞、霍奇金细胞、组织细胞、淋巴细胞、纤维化、胶原化改变)的优势均与预后无关(P>0.05)。然而,临床分期、近期疗效及治疗方法对预后有显著影响(P<0.05)。作者认为,强化化疗联合放疗以及强化放疗可使患者长期存活。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验